A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumors.
about
Vitamin D and urological cancersCalcitriol in Combination Therapy for Prostate Cancer: Pharmacokinetic and Pharmacodynamic InteractionsA vitamin D receptor-alkylating derivative of 1α,25-dihydroxyvitamin D3 inhibits growth of human kidney cancer cells and suppresses tumor growth.1α,25-Dihydroxyvitamin D3-3β-bromoacetate, a potential cancer therapeutic agent: synthesis and molecular mechanism of action.Vitamin D and cancer: clinical aspects.A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer.Vitamin d: pharmacokinetics and safety when used in conjunction with the pharmaceutical drugs used in cancer patients: a systematic review.The role of vitamin D in cancer prevention and treatment.The role of vitamin D in cancer prevention and treatment.Current progress in using vitamin D and its analogs for cancer prevention and treatment.Nitric oxide release from trigeminal satellite glial cells is attenuated by glial modulators and glutamateGSK-3 Inhibition Sensitizes Acute Myeloid Leukemia Cells to 1,25D-Mediated DifferentiationOral bioavailability of DN101, a concentrated formulation of calcitriol, in tumor-bearing dogs.Vitamin D in prostate cancer.
P2860
Q26739735-1A210E9E-8FC8-415A-8A43-EDAD909B649AQ26766242-FEF4770A-6502-4525-BF6A-89EB25EA2225Q34689137-98D4FD07-8F76-4997-8EA4-5AB0992261D6Q34778161-3DE9E1D6-FD67-48E8-9335-99B2F1A29AC7Q36509508-36DB6672-33CA-4166-B326-D21CB922DA00Q36799473-2532D374-8A46-45AE-855F-847CCB2C5DEDQ37061744-EFFC81F9-87EC-431D-B241-FF2A627A3ACEQ37761548-EA354426-C8DD-4439-A3D5-7E1CC22D75FEQ38004753-386EDD1E-198A-4146-A476-6B81E1AFEDCBQ38020247-81AACFD6-E384-4292-99F1-BE3422AE3EBAQ39282066-AC36FEF3-B753-4A0B-A3FE-21586962C38AQ41461266-C77A60B0-DA5C-47A6-98B3-E0D26CA06D41Q50309039-B9FAB614-C094-4A96-AF0E-10ACE8FDB425Q55024961-A1E8B02F-C7E7-4A00-B1CE-3650D75D91FC
P2860
A phase I and pharmacokinetics study of intravenous calcitriol in combination with oral dexamethasone and gefitinib in patients with advanced solid tumors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A phase I and pharmacokinetics ...... ts with advanced solid tumors.
@en
A phase I and pharmacokinetics ...... ts with advanced solid tumors.
@nl
type
label
A phase I and pharmacokinetics ...... ts with advanced solid tumors.
@en
A phase I and pharmacokinetics ...... ts with advanced solid tumors.
@nl
prefLabel
A phase I and pharmacokinetics ...... ts with advanced solid tumors.
@en
A phase I and pharmacokinetics ...... ts with advanced solid tumors.
@nl
P2093
P2860
P1476
A phase I and pharmacokinetics ...... ts with advanced solid tumors.
@en
P2093
Candace S Johnson
Donald L Trump
Josephia R Muindi
Kristie L Engler
Marwan G Fakih
Renee Christy
P2860
P2888
P356
10.1007/S00280-009-1000-2
P577
2009-04-26T00:00:00Z